Invitrogen™ Kallikrein 9 Polyclonal Antibody

Goat Polyclonal Antibody

Supplier:  Invitrogen™ PA547497

Catalog No. PIPA547497

Description

In direct ELISAs and Western blots, less than 1% cross-reactivity with recombinant human KLK-1, -3, -4, -5, -6, -7, -8, -10, -11, -12, -13, -14, and -15 is observed. Reconstitute at 0.2 mg/mL in sterile PBS.

Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. KLK9 is a novel kallikrein with potential application for diagnosis, monitoring and therapeutics of various cancers including those of the breast, prostate and testis.

Specifications

• Antigen: Kallikrein 9
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: KLK9
• Gene Alias: 1200016C12Rik; AI324041; kallikrein 9; kallikrein related peptidase 9; kallikrein related-peptidase 9; kallikrein-9; Kallikrein-like protein 3; kallikrein-related peptidase 9; KLK9; KLK-9; KLKL3; KLK-L3
• Host Species: Goat
• Purification Method: Antigen Affinity Chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 284366
• Content And Storage: -20°C, Avoid Freeze/Thaw Cycles
• Form: Lyophilized

• Applications: Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot
• Concentration: 0.2 mg/mL
• Formulation: PBS with 5% trehalose and No Preservative
• Gene Accession No.: Q9UKQ9
• Gene Symbols: KLK9
• Immunogen: Mouse myeloma cell line NS0-derived recombinant human Kallikrein 9 Asp20-Asn250.
• Quantity: 100 μg
• Primary or Secondary: Primary
• Target Species: Human
• Product Type: Antibody
• Isotype: IgG